Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals.

ABSTRACT:

Background

Whole-body magnetic resonance imaging (WB-MRI) has emerged as a valuable tool for cancer detection. This study evaluated the prevalence rates of cancer in asymptomatic individuals undergoing WB-MRI according to the Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) classifications in order to assess the reliability of the classification method.

Methods

We retrospectively enrolled 2064 asymptomatic individuals who participated in a WB-MRI cancer screening program between 2017 and 2022. WB-MRI was acquired on a 3-T system with a standard protocol, including regional multisequence and gadolinium-based contrast agent-enhanced oncologic MRI. Results of further examinations, including additional imaging and histopathology examinations, performed at ou

SUBMITTER: Hu YS 

PROVIDER: S-EPMC10848416 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature